SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp. (SpaceX) designs, manufactures, and launches advanced rockets and spacecraft, including the fully reusable Starship and Super Heavy rocket system, targeting missions to Earth orbit, the Moon, Mars, and beyond. The company is based in Hawthorne, CA and has subsidiaries in Luxembourg and the United States. The company operates Starlink, a low-Earth orbit satellite constellation that delivers high-speed broadband internet worldwide. SpaceX is dedicated to advancing space technology with the goal of enabling human life on other planets. The company was founded in 2002 by Elon Reeve Musk, Kimbal Musk, Michael Kives. Elon Reeve Musk has been the CEO since 2002.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is currently the focus of intense investor debate surrounding the successful 13th Starship test flight and Starlink satellite deployment, with market participants weighing these technical achievements against concerns over valuation, short interest, and upcoming share lock-up expirations. The community remains deeply divided, as bulls view recent mission milestones as confirmation of the company's long-term growth potential, while bears focus on speculative pricing, lack of profitability, and potential downward pressure from insider selling.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is seeing intense trading activity as an FDA advisory committee begins recommending the inclusion of several popular peptides on the compounding list, fueling investor optimism over a significant new revenue stream. While the broader healthcare sector faces downward pressure, the community is actively debating the stock's potential for a short squeeze given the high short interest and the strategic value of these regulatory milestones for the company's long-term growth.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce shares are drawing interest as investors debate the impact of agentic AI on enterprise software, with recent analyst upgrades highlighting attractive valuations and high-margin AI monetization through platforms like Agentforce. While some community members express frustration over price volatility and sector-wide sentiment swings, others maintain a bullish long-term perspective, viewing the current setup as a potential entry point for high-quality software names.

Xanadu Quantum Technologies Ltd. engages in the provision of quantum computing solutions for enterprise and government customers. The company was founded by Christian Weedbrook on October 2, 2025 and is headquartered in Toronto, Canada.

Xanadu Quantum Technologies Ltd. - Ordinary Shares - Class B (Sub Voting)

Xanadu Quantum Technologies is trending as investors weigh its recent algorithmic breakthroughs and potential government funding against concerns regarding high valuation, dilution, and long-term scaling challenges in the photonic quantum sector. The community remains divided, with some betting on a massive rebound driven by state-backed support, while others warn of significant volatility and the early-stage nature of its research-heavy business model.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is experiencing heightened volatility following a negative opinion from the EMA's CHMP regarding the marketing authorization for its Niemann-Pick disease treatment, arimoclomol. While community members express frustration over the regulatory setback and potential impacts on European access, many investors are focused on the company's established U.S. revenue, cash position, and plans to request a formal re-examination as reasons to remain long.

Wolfspeed, Inc. is an innovator of wide bandgap semiconductors, focused on silicon carbide and gallium nitride (GaN) materials and devices for power and radiofrequency (RF) applications. Its product families include silicon carbide and GaN materials, power devices and RF devices, and its products are targeted for various applications such as electric vehicles, fast charging, 5G, renewable energy and storage, and aerospace and defense. The company was founded by Calvin H. Carter Jr., John W. Palmour, F. Neal Hunter, Eric Hunter, and John Edmond in 1987 and is headquartered in Durham, NC.

Wolfspeed Inc - Ordinary Shares (New)

Wolfspeed Inc

Wolfspeed is experiencing significant volatility driven by intense retail debate over its massive short interest and potential for a squeeze, coupled with skepticism regarding its ability to scale production at the Siler City facility. While the company's expansion into data center solutions and high-voltage power modules for aerospace has generated buzz, sentiment remains divided between those betting on a parabolic reversal and critics highlighting persistent debt concerns and underutilized manufacturing capacity.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network (ZBCN) remains a polarizing topic in the community, with long-term investors pointing to ongoing infrastructure development and upcoming regulatory milestones like the Clarity Act as reasons for optimism. While some participants are aggressively accumulating during current market volatility, others express frustration over stagnant price action and are questioning the project's ability to maintain momentum amidst broader market uncertainty.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel shares are experiencing significant volatility following a better-than-expected earnings report, as investors weigh strong revenue growth against concerns over increased capital expenditure and broader semiconductor sector weakness. While the community is debating whether the sell-off is a temporary overreaction or a sign of deeper structural risks, many are actively discussing potential swing trade opportunities and questioning the influence of market makers on the stock's sudden reversal.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Menlo Park, CA.

Snowflake Inc

Snowflake is seeing a major surge in investor interest and stock price momentum as enterprise adoption of its AI-driven data platform accelerates, reinforcing its position as a central player in AI infrastructure. Community discourse remains heavily focused on the company's resilient cloud metrics and strategic AI partnerships, with many market participants viewing the current strength as a broader re-rating of the software sector's AI monetization potential.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. The firm focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPMorgan Chase & Co. (JPM) is currently trending due to a combination of strong institutional demand for its structured products and the bank's proactive stance on integrating autonomous AI agents into its operational workflows. The community is actively discussing JPM's role as a market leader, with significant focus on its recent record-breaking earnings, institutional order flow, and strategic moves that continue to drive its market influence.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know  

Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.

Novartis Q2 Earnings & Revenues Top Estimates, Key Drugs Perform Well

Novartis tops Q2 earnings and revenue estimates as growth from key brands offsets generic pressure, while reaffirming 2026 guidance and advancing acquisitions.

Novavax (NVAX) Registers a Bigger Fall Than the Market: Important Facts to Note

Novavax (NVAX) reached $7.88 at the closing of the latest trading day, reflecting a -4.02% change compared to its last close.

HRMY Posts Preliminary Q2 Revenues, Announces CFO Transition

Harmony Biosciences posts preliminary Q2 2026 Wakix revenues of about $261M, up 30% year over year, while reaffirming full-year guidance despite a CFO transition.

NVO Stock Up on EC Approval of Wegovy Pill to Treat Obesity 

Novo Nordisk wins EC approval for a once-daily oral Wegovy pill for obesity, expanding its EU franchise with the first GLP-1 tablet for weight management.

Novavax (NVAX) Stock Sinks As Market Gains: Here's Why

In the latest trading session, Novavax (NVAX) closed at $8.42, marking a -5.5% move from the previous day.

AGEN Stock Jumps on Securing $340M Financing to Fund Strategic Pivot

Agenus surges after securing up to $340M in financing to fund its phase III ROBBIN colon cancer study and extend its cash runway if warrants are exercised.

FBRX Stock Rallies 78% on Positive Early-Stage Vitiligo Study Data

Forte Biosciences stock soars after early-stage data show FB102 significantly improves facial depigmentation in vitiligo with a favorable safety profile.

TVRD Stock Rallies 149% So Far This Week: Here's What You Should Know

Tvardi Therapeutics stock jumps this week as phase I data for TTI-109 highlight improved tolerability, target engagement and support plans for mid-stage development.

Novavax (NVAX) Suffers a Larger Drop Than the General Market: Key Insights

Novavax (NVAX) concluded the recent trading session at $9.35, signifying a -1.16% move from its prior day's close.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

MRNA, INO, SABS, NVAX Stocks Jump Premarket: Deadly Hantavirus Reaches US After Cruise Ship Outbreak 

Equity

Bearish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards another losing week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$7.46
Prev Close	$7.83
Open	$7.90
Dividend Yield	0.00%
50-Day Moving Average	$9.15
Beta	1.48
Avg. Volume	4.59M
PE Ratio	-12.48

52-Week High	$11.97
52-Week Low	$6.20
Market Capitalization	$1.29B
EPS (Annual)	$2.54
Price to Book	-8.47
Revenue Per Employee	$1.5M

Feed

News

Sentiment

Earnings

Fundamentals

Info

NVAXNovavax Inc

Latest NVAX News